- Home
- GNTX vs PCVX Comparison
GNTX vs PCVX Comparison
Compare GNTX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNTX
- PCVX
- Stock Information
- Founded
- GNTX 1974
- PCVX 2013
- Country
- GNTX United States
- PCVX United States
- Employees
- GNTX N/A
- PCVX N/A
- Industry
- GNTX Auto Parts:O.E.M.
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- GNTX Consumer Discretionary
- PCVX Health Care
- Exchange
- GNTX Nasdaq
- PCVX Nasdaq
- Market Cap
- GNTX 4.8B
- PCVX 4.4B
- IPO Year
- GNTX N/A
- PCVX 2020
- Fundamental
- Price
- GNTX $21.90
- PCVX $32.94
- Analyst Decision
- GNTX Buy
- PCVX Strong Buy
- Analyst Count
- GNTX 7
- PCVX 10
- Target Price
- GNTX $27.50
- PCVX $136.50
- AVG Volume (30 Days)
- GNTX 2.1M
- PCVX 1.5M
- Earning Date
- GNTX 07-25-2025
- PCVX 08-05-2025
- Dividend Yield
- GNTX 2.19%
- PCVX N/A
- EPS Growth
- GNTX N/A
- PCVX N/A
- EPS
- GNTX 1.72
- PCVX N/A
- Revenue
- GNTX $2,299,862,212.00
- PCVX N/A
- Revenue This Year
- GNTX $7.38
- PCVX N/A
- Revenue Next Year
- GNTX $7.17
- PCVX N/A
- P/E Ratio
- GNTX $12.77
- PCVX N/A
- Revenue Growth
- GNTX N/A
- PCVX N/A
- 52 Week Low
- GNTX $20.28
- PCVX $27.66
- 52 Week High
- GNTX $35.32
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- GNTX 51.21
- PCVX 46.08
- Support Level
- GNTX $21.05
- PCVX $32.06
- Resistance Level
- GNTX $22.15
- PCVX $33.81
- Average True Range (ATR)
- GNTX 0.44
- PCVX 1.23
- MACD
- GNTX 0.05
- PCVX -0.12
- Stochastic Oscillator
- GNTX 59.51
- PCVX 19.86
About GNTX Gentex Corporation
Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.